TrialNephron2024

Efficacy and Safety of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in Chinese Dialysis Patients with Hyperphosphataemia: A Randomised, Open-Label, Multicentre, 12-Week Phase III Study.

Jun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.